Chemoinformaics analysis of alpha-spinasteryl glucoside
| Molecular Weight | 574.843 | nRot | 8 |
| Heavy Atom Molecular Weight | 516.379 | nRig | 27 |
| Exact Molecular Weight | 574.423 | nRing | 5 |
| Solubility: LogS | -4.789 | nHRing | 1 |
| Solubility: LogP | 5.364 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 101.936 |
| nHD | 4 | BPOL | 61.658 |
| QED | 0.281 |
| Synth | 5.245 |
| Natural Product Likeliness | 2.812 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.041 |
| Pgp-sub | 0.005 |
| HIA | 0.13 |
| CACO-2 | -4.85 |
| MDCK | 0.0000405 |
| BBB | 0.073 |
| PPB | 0.98688 |
| VDSS | 1.604 |
| FU | 0.0113499 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.285 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.807 |
| CYP2c9-inh | 0.034 |
| CYP2c9-sub | 0.087 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.24 |
| CYP3a4-inh | 0.317 |
| CYP3a4-sub | 0.559 |
| CL | 3.806 |
| T12 | 0.016 |
| hERG | 0.005 |
| Ames | 0.036 |
| ROA | 0.112 |
| SkinSen | 0.01 |
| Carcinogencity | 0.027 |
| EI | 0.006 |
| Respiratory | 0.633 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.614327 |